cytidine monophosphate has been researched along with Leukemia, Myeloid, Acute in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 11 (61.11) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatta, Y; Hirabayashi, Y; Horikoshi, A; Iriyama, N; Kobayashi, S; Kodaira, H; Matsukawa, Y; Miura, K; Takahashi, H; Takeuchi, J; Uchino, Y | 1 |
| Arahata, M; Asakura, H; Nakao, S; Shimizu, Y | 1 |
| Horikoshi, A; Hosokawa, Y; Sawada, S; Takei, K | 1 |
| Cailla, H; Carcassonne, Y; Gastaut, JA; Maraninchi, D; Scavennec, J | 1 |
| Cheng, YC; Mancini, WR | 1 |
| Arie, Y; Hirai, M; Kikukawa, M; Kodo, H; Kumakawa, T; Mizutani, R; Mori, M; Murai, Y; Nakamura, N; Tsutsumi, H | 1 |
| Braess, J; Hiddemann, W; Kaufmann, C; Ramsauer, B; Schleyer, E; Schüssler, M; Unterhalt, M; Wilde, S | 1 |
| Niitsu, N; Shikoshi, K; Takada, M; Umeda, M | 1 |
| Fujita, N; Goto, H; Hirata, T; Inaba, T; Miyazaki, S; Nakagawa, M; Shimazaki, C; Tatsumi, T; Yamagata, N | 1 |
| Hernández, DE; Pellino, ML; Ramírez, B | 1 |
| Endo, M; Iki, S; Ito, K; Kitazume, K; Urabe, A; Usuki, K | 1 |
| Chuhjo, T; Katoh, T; Kaya, H; Matano, S; Matsuda, T; Murashima, M; Nakamura, S; Ohtake, S; Okumura, H; Takamatsu, H; Takeshima, M; Watanabe, A; Yamauchi, H; Yoshida, T | 1 |
| Fujisawa, S; Matsui, H; Yano, K | 1 |
| Ito, T; Konishi, H; Maesako, Y; Mori, S; Ueda, Y; Yagiri, Y | 1 |
| Brown, KR; Chen, S; Choi, BY; Lin, ZY; Skalski, V | 1 |
| Mekosh, HL; Perrino, FW | 1 |
| Fukuoka, M; Hattori, M; Hirota, Y; Miyazaki, T; Nakamura, T; Niitani, H; Ohta, K; Suzuoki, Y; Tanaka, M; Yoshida, Y | 1 |
| Grisé-Miron, L; Labonté, L; Leclerc, JM | 1 |
5 trial(s) available for cytidine monophosphate and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
The value of oral cytarabine ocfosfate and etoposide in the treatment of refractory and elderly AML patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local | 2008 |
Pharmacokinetics of Ara-CMP-Stearate (YNK01): phase I study of the oral Ara-C derivative.
Topics: Administration, Oral; Antineoplastic Agents; Arabinofuranosyluracil; Arabinonucleotides; Cytarabine; Cytidine Monophosphate; Dose-Response Relationship, Drug; Half-Life; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Statistics, Nonparametric | 1995 |
Treatment of acute myeloid leukemia and myelodysplastic syndrome with orally administered cytarabine ocfosfate and granulocyte colony-stimulating factor.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes | 1997 |
[A pharmacokinetic study of the value of oral cytarabine ocfosfate in the treatment of hematological malignancies].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Arabinonucleotides; Cytarabine; Cytidine Monophosphate; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Time Factors | 1998 |
[Phase I study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate)].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Diarrhea; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Middle Aged; Myelodysplastic Syndromes; Nausea; Vomiting | 1990 |
13 other study(ies) available for cytidine monophosphate and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Efficacy of oral cytarabine ocfosfate and etoposide in the treatment of elderly patients with higher-risk myelodysplastic syndromes compared to that in elderly acute myeloid leukemia patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cytidine Monophosphate; Disease-Free Survival; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Treatment Outcome | 2013 |
Persistent molecular remission of refractory acute myeloid leukemia with inv(16)(p13.1q22) in an elderly patient induced by cytarabine ocfosfate hydrate.
Topics: Aged; Antineoplastic Agents; Arabinonucleotides; Chromosome Inversion; Chromosomes, Human, Pair 16; Cytidine Monophosphate; Female; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Remission Induction | 2015 |
2' and 3' ribonucleoside monophosphate in leukocytes of acute myeloid leukemia: markers for early diagnosis of relapse.
Topics: Adenosine Monophosphate; Adult; Bone Marrow; Chromatography, High Pressure Liquid; Cytidine Monophosphate; Female; Guanosine Monophosphate; Humans; Leukemia, Myeloid, Acute; Leukocytes; Male; Middle Aged; Recurrence; Ribonucleotides; Uridine Monophosphate | 1982 |
Human deoxycytidylate deaminase. Substrate and regulator specificities and their chemotherapeutic implications.
Topics: Allosteric Regulation; Arabinonucleotides; Cytidine Monophosphate; DCMP Deaminase; Deoxyadenine Nucleotides; Deoxycytosine Nucleotides; Deoxyguanine Nucleotides; Deoxyuracil Nucleotides; Guanosine Monophosphate; Humans; Leukemia, Myeloid, Acute; Nucleotide Deaminases; Substrate Specificity; Thymine Nucleotides | 1983 |
[Plasma concentration of cytosine arabinoside (Ara-C) in the elderly patients with hematological malignancy treated by Ara-C or cytarabine ocfosfate (SPAC)].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Arabinonucleotides; Cytarabine; Cytidine Monophosphate; Female; Humans; Infusions, Intravenous; Injections, Subcutaneous; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes | 1995 |
[Therapy-related acute non-lymphocytic leukemia (M2) with 7;11 chromosome translocation induced into complete remission by low dose cytosine arabinoside and cytarabine ocfosfate therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 7; Cytarabine; Cytidine Monophosphate; Female; Humans; Leukemia, Myeloid, Acute; Neoplasms, Second Primary; Remission Induction; Translocation, Genetic | 1994 |
[Successful treatment of acute myelogenous leukemia in an elderly patient with cytarabine ocfosfate].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Arabinonucleotides; Cerebral Infarction; Cytidine Monophosphate; Dementia, Vascular; Female; Humans; Leukemia, Myeloid, Acute; Remission Induction | 1994 |
Acute myelocytic leukaemia associated with Kaposi's sarcoma in a patient without serum antibodies to human immunodeficiency virus type 1.
Topics: Adult; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; HIV Antibodies; HIV-1; Humans; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Sarcoma, Kaposi | 1996 |
Combination therapy with granulocyte colony-stimulating factor, all-trans retinoic acid, and low-dose cytotoxic drugs for acute myelogenous leukemia.
Topics: Aged; Antineoplastic Agents; Arabinonucleotides; Bone Marrow; Cyclophosphamide; Cytidine Monophosphate; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Tretinoin | 1995 |
[Oral administration of cytarabine ocfosfate and ondansetron hydrochloride in patients with acute myeloid leukemia who can not be treated with intensive chemotherapy:--attempt to make their quality of life better].
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Ondansetron; Quality of Life | 1998 |
A 3'-5' exonuclease in human leukemia cells: implications for resistance to 1-beta -D-arabinofuranosylcytosine and 9-beta -D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate.
Topics: Antimetabolites, Antineoplastic; Arabinonucleotides; Cell Nucleus; Cells, Cultured; Cytidine Monophosphate; DNA-Directed DNA Polymerase; Drug Resistance, Neoplasm; Exodeoxyribonuclease V; Exodeoxyribonucleases; Exonucleases; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphocytes; Magnesium; Neoplasm Proteins; Potassium Chloride; Protein Biosynthesis; Time Factors; Transcription, Genetic; Tumor Cells, Cultured; Up-Regulation; Vidarabine Phosphate | 2000 |
Incorporation of cytosine arabinoside monophosphate into DNA at internucleotide linkages by human DNA polymerase alpha.
Topics: Adenosine Triphosphate; Arabinonucleotides; Chromatography, Affinity; Cytidine Monophosphate; DNA; DNA Polymerase II; Humans; Kinetics; Leukemia, Myeloid, Acute; Leukocytes; Templates, Genetic | 1992 |
Inhibition of DNA polymerase-alpha by ara-CMP in the presence of a regulatory protein extracted from human promyelocytic leukemic cells (HL-60).
Topics: Acute Disease; Arabinonucleotides; Cell Line; Cytidine Monophosphate; Cytosine Nucleotides; Deoxycytidine Monophosphate; DNA Polymerase II; DNA-Binding Proteins; Humans; Leukemia; Leukemia, Myeloid, Acute; Molecular Weight; Uridine Monophosphate | 1987 |